Allogene Therapeutics (ALLO) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Allogene Therapeutics (ALLO) Interest Coverage Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -11.54% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 82.53% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 43.08% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 28.57% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -26.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -24.77% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 33.30% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 81.16% |
| 10 | Allogene Therapeutics | 707.96 Mn | 707.96 Mn | - | 7.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.64% |
| Mar 31, 2026 | 76.14% |
| Dec 31, 2025 | 37.00% |
| Sep 30, 2025 | -47.52% |
| Jun 30, 2025 | 1.74% |
| Mar 31, 2025 | 51.27% |
| Dec 31, 2024 | -700.61% |
| Sep 30, 2024 | -78.03% |
| Jun 30, 2024 | 15.05% |
| Mar 31, 2024 | 46.42% |
| Dec 31, 2023 | 29.20% |
| Sep 30, 2023 | -81.29% |
| Jun 30, 2023 | -117.87% |
| Mar 31, 2023 | -253.43% |
| Dec 31, 2022 | 61.30% |
| Sep 30, 2022 | 42.95% |
| Jun 30, 2022 | 25.28% |
| Mar 31, 2022 | -373.29% |
| Dec 31, 2021 | -22.67% |
| Sep 30, 2021 | 47.68% |